M Weller
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.
Zeitlberger A, Putora P, Hofer S, Schucht P, Migliorini D, Hottinger A, Roelcke U, Läubli H, Spina P, Bozinov O, Weller M, Neidert M, Hundsberger T. Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis. J Neurooncol 2022; 158:359-367.
29.04.2022Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.
29.04.2022J Neurooncol 2022; 158:359-367
Zeitlberger A M, Putora Paul Martin, Hofer S, Schucht P, Migliorini D, Hottinger A F, Roelcke U, Läubli H, Spina P, Bozinov Oliver, Weller M, Neidert M, Hundsberger Thomas
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Wirsching H, Riklin C, Felsberg J, Roth P, Jones D, Pfister S, Rushing E, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Weller M. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol 2018; 29:1423-1430.
01.06.2018Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
01.06.2018Ann Oncol 2018; 29:1423-1430
Wirsching H-G, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm Ludwig, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger Thomas, Weller M
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes
Hundsberger T, Weller M, Plasswilm L, Brügge D, Gross M, Pica A, Hermann E, Pesce G, Conen K, Dietrich P, Migliorini D, Roth P, Roelcke U, Hottinger A, Putora P. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. J Neurooncol 2016; 126:175-183.
01.01.2016Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes
01.01.2016J Neurooncol 2016; 126:175-183
Hundsberger Thomas, Weller M, Plasswilm Ludwig, Brügge Detlef, Gross M W, Pica A, Hermann E, Pesce G, Conen K, Dietrich P Y, Migliorini D, Roth P, Roelcke U, Hottinger A F, Putora Paul Martin
Cetuximab induced aseptic meningitis.
Ulrich A, Weiler S, Weller M, Rordorf T, Tarnutzer A. Cetuximab induced aseptic meningitis. J Clin Neurosci 2015; 22:1061-3.
11.03.2015Cetuximab induced aseptic meningitis.
11.03.2015J Clin Neurosci 2015; 22:1061-3
Ulrich A, Weiler S, Weller M, Rordorf Tamara, Tarnutzer A A
Multifocal CNS demyelination after octreotide treatment for metastatic meningioma
Schreglmann S, Jelčić I, Taegtmeyer A, Linnebank M, Weller M. Multifocal CNS demyelination after octreotide treatment for metastatic meningioma. Clin Neurol Neurosurg 2012; 115:817-9.
05.08.2012Multifocal CNS demyelination after octreotide treatment for metastatic meningioma
05.08.2012Clin Neurol Neurosurg 2012; 115:817-9
Schreglmann S, Jelčić I, Taegtmeyer A B, Linnebank M, Weller M
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger T, Weller M, Martus P, Roth P, Klasen H, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Ann Oncol 2012; 23:2374-2380.
05.03.2012Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
05.03.2012Ann Oncol 2012; 23:2374-2380
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H-G, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger Thomas, Weller M, Martus P, Roth P, Klasen H A, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L